322 related articles for article (PubMed ID: 10387011)
1. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
[TBL] [Abstract][Full Text] [Related]
2. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L
Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744
[TBL] [Abstract][Full Text] [Related]
3. DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
Bailly C; Laine W; Baldeyrou B; De Pauw-Gillet MC; Colson P; Houssier C; Cimanga K; Van Miert S; Vlietinck AJ; Pieters L
Anticancer Drug Des; 2000 Jun; 15(3):191-201. PubMed ID: 11049087
[TBL] [Abstract][Full Text] [Related]
4. The plant alkaloid usambarensine intercalates into DNA and induces apoptosis in human HL60 leukemia cells.
Dassonneville L; Wattez N; Mahieu C; Colson P; Houssier C; Frederich M; Tits M; Angenot L; Bailly C
Anticancer Res; 1999; 19(6B):5245-50. PubMed ID: 10697543
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
[TBL] [Abstract][Full Text] [Related]
6. The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites.
Lisgarten JN; Coll M; Portugal J; Wright CW; Aymami J
Nat Struct Biol; 2002 Jan; 9(1):57-60. PubMed ID: 11731803
[TBL] [Abstract][Full Text] [Related]
7. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine.
Ansah C; Khan A; Gooderham NJ
Toxicology; 2005 Mar; 208(1):141-7. PubMed ID: 15664441
[TBL] [Abstract][Full Text] [Related]
8. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
9. Synthetic cryptolepine inhibits DNA binding of NF-kappaB.
Olajide OA; Heiss EH; Schachner D; Wright CW; Vollmar AM; Dirsch VM
Bioorg Med Chem; 2007 Jan; 15(1):43-9. PubMed ID: 17064915
[TBL] [Abstract][Full Text] [Related]
10. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of HL-60 leukemia cells induced by the bisindole alkaloids sungucine and isosungucine from Strychnos icaja.
Lansiaux A; Bailly C; Houssier C; Colson P; De Pauw-Gillet MC; Frédérich M; Tits M; Angenot L
Planta Med; 2002 Jul; 68(7):591-5. PubMed ID: 12142990
[TBL] [Abstract][Full Text] [Related]
12. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
[TBL] [Abstract][Full Text] [Related]
14. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest.
Yang SW; Abdel-Kader M; Malone S; Werkhoven MC; Wisse JH; Bursuker I; Neddermann K; Fairchild C; Raventos-Suarez C; Menendez AT; Lane K; Kingston DG
J Nat Prod; 1999 Jul; 62(7):976-83. PubMed ID: 10425120
[TBL] [Abstract][Full Text] [Related]
16. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
17. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
Bierer DE; Fort DM; Mendez CD; Luo J; Imbach PA; Dubenko LG; Jolad SD; Gerber RE; Litvak J; Lu Q; Zhang P; Reed MJ; Waldeck N; Bruening RC; Noamesi BK; Hector RF; Carlson TJ; King SR
J Med Chem; 1998 Mar; 41(6):894-901. PubMed ID: 9526563
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
[TBL] [Abstract][Full Text] [Related]
19. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
Báez A; Riou JF; Le Pecq JB; Riou G
Mol Pharmacol; 1990 Mar; 37(3):377-82. PubMed ID: 2156151
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta.
Cimanga K; De Bruyne T; Pieters L; Vlietinck AJ; Turger CA
J Nat Prod; 1997 Jul; 60(7):688-91. PubMed ID: 9249972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
